Thrilled to share that the DESTINATION 2 trial has received the green light for recruitment at The Christie! Looking forward to welcoming patients and making meaningful progress together #clinicaltrials #thechristie #oncologyresearch #prostatecancer
@momentumstudy.bsky.social
Congratulations to our very own Liz Miles, incredible colleague, mentor & friend on her #ESTRO25 Interdisciplinary Award. A true champion for #collaboration and #RTQA. So well deserved- we could not be prouder!
Regional LN delineation variability in #BrCa RT within the Fast Forward trial. Despite this variability, all mandatory constraints were adhered to. #RTQA plays a central role in providing support & guidance to participating centres www.sciencedirect.com/science/arti...
Regional Lymph Node Delineation variability and its Dosimetric Impact in Breast Cancer Radiotherapy
To quantify the interobserver variability of regional lymph node delineation for breast cancer radiotherapy (RT) and establish whether a relationship …
sciencedirect.com
We are thrilled to announce opening of the ANDROMEDA study! This represents another significant achievement stemming from MOMENTUM infrastructure. We’re excited to leverage our advanced Unity MR-Linac capabilities to deliver dose-escalated adaptive radiotherapy for patients with rectal cancer.
Happy to announce that the 7000th participant for MOMENTUM has been enrolled at UMC Utrecht yesterday!
For muscle-invasive bladder cancer, the Lancet Oncology paper by Zlotta et al is the best comparative effectiveness study of TMT versus RC. How can we use this study to communicate the risks of delayed cystectomy to patients? Peppin A et al provide an answer at GU ASCO 2025:
UCL Innovative Clinical Trials Unit@innovative-ctu.bsky.social · 2y agoMost men with advanced #ProstateCancer benefit from new-generation drugs targeting the androgen receptor (ARPIs), but older patients may benefit from some ARPIs more than others. These results from the STOPCAP meta-analysis were presented at #ASCOGU25 by @dfishstats.bsky.social.
www.phiro.science/article/S240... Another elegant demonstration of how simplifying complex workflows yields powerful results. By leveraging MOMENTUM's infrastructure, this team shows streamlined adaptive radiotherapy maintains quality while reducing treatment times. Congratulations!
A simplified online adaptive workflow for long-course magnetic resonance-guided radiotherapy in esophageal cancer
Since the publication of the landmark CROSS trial in 2012 [1], neoadjuvant chemoradiotherapy has become a cornerstone in the curative treatment of esophageal cancer in much of the western world. The r...
phiro.science